Indian Company Master Data Made Simple
Bal Pharma Limited
Profile data last updated: 19/12/2024
Bal Pharma Limited, founded in 1987, carries 38 years of experience in its sector. Corporate Identification Number is L85110KA1987PLC008368 and its registration number is 8368. The organization is recorded as company limited by shares under Indian company law. The company has an authorized share capital of ₹20.00 crore. This company’s paid-up capital is valued at ₹15.92 crore.
Its principal business sector is human health activities. Bal Pharma Limited is officially registered in Bangalore. The firm’s incorporation address reads 21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099. Bal Pharma Limited remains active and operational. Bal Pharma Limited is registered with the PAN code AABCB0512E. Bal Pharma Limited is identified globally under LEI 254900F3KMK38GUDIW74. All official communications can be sent to [email protected]. Bal Pharma Limited’s leadership roster features Daddanala Venkat Bharath Bhushan (CFO).
Company Overview
- CIN
- Date of Incorporation
- 19/05/1987
- Company Status
- Active
- RoC
- Bangalore
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹20,00,00,000.00
- Paid up Capital
- ₹15,92,08,720.00
- Activity
- Human health activities
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹3,878.56L | ₹4,480.96L | ₹4,013.57L | ₹3,639.56L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹25,828.59L | ₹24,786.68L | ₹24,947.01L | ₹20,204.03L | ₹0.00L |
| Tangible Book Value | ₹6,159.15L | ₹5,679.62L | ₹4,950.35L | ₹4,680.70L | ₹0.00L |
| Long Term Debt | ₹3,141.34L | ₹3,634.94L | ₹3,052.31L | ₹2,701.35L | ₹0.00L |
| Long Term Provisions | ₹564.46L | ₹508.60L | ₹506.75L | ₹469.41L | ₹0.00L |
| Goodwill | ₹382.69L | ₹382.69L | ₹382.86L | ₹382.86L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹11,899.98L | ₹10,452.68L | ₹10,133.11L | ₹7,738.92L | ₹0.00L |
| Total Assets | ₹33,569.02L | ₹31,983.83L | ₹31,317.23L | ₹26,053.27L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹7,740.44L | ₹7,197.15L | ₹6,370.22L | ₹5,849.24L | ₹0.00L |
| Gross PPE | ₹7,377.63L | ₹11,282.60L | ₹10,336.27L | ₹9,580.34L | ₹0.00L |
| Total Capitalization | ₹10,882.93L | ₹10,835.38L | ₹9,431.22L | ₹8,564.03L | ₹0.00L |
| Common Stock | ₹1,592.09L | ₹1,580.44L | ₹1,568.99L | ₹1,482.24L | ₹0.00L |
| Total Debt | ₹15,041.32L | ₹14,225.04L | ₹13,307.92L | ₹10,665.64L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹1,582.44L | ₹1,520.82L | ₹1,428.56L | ₹1,181.98L | ₹0.00L |
| Other Equity Interest | ₹6,149.50L | ₹66.55L | ₹139.26L | ₹185.03L | ₹0.00L |
| Capital Stock | ₹1,592.09L | ₹1,580.44L | ₹1,568.99L | ₹1,482.24L | ₹0.00L |
| Total Non Current Assets | ₹10,081.83L | ₹8,567.67L | ₹8,501.64L | ₹7,596.24L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹1,041.02L | ₹1,992.90L | ₹746.27L | ₹608.45L | ₹0.00L |
| Invested Capital | ₹22,779.61L | ₹21,160.34L | ₹19,478.84L | ₹16,226.76L | ₹0.00L |
| Net Tangible Assets | ₹6,159.15L | ₹5,679.62L | ₹4,950.35L | ₹4,680.70L | ₹0.00L |
| Cash And Cash Equivalents | ₹175.16L | ₹419.57L | ₹148.71L | ₹111.28L | ₹0.00L |
| Prepaid Assets | ₹2,205.18L | ₹2,084.86L | ₹2,331.69L | ₹1,953.27L | ₹0.00L |
| Stockholders Equity | ₹7,741.59L | ₹7,200.44L | ₹6,378.91L | ₹5,862.68L | ₹0.00L |
| Other Short Term Investments | ₹865.86L | ₹1,573.33L | ₹597.56L | ₹497.17L | ₹0.00L |
| Share Issued | ₹159.21L | ₹158.04L | ₹156.90L | ₹155.72L | ₹0.00L |
| Current Assets | ₹23,487.20L | ₹23,416.16L | ₹22,815.59L | ₹18,457.03L | ₹0.00L |
| Working Capital | ₹1,537.17L | ₹3,110.44L | ₹1,882.15L | ₹1,892.56L | ₹0.00L |
| Net Debt | ₹14,862.86L | ₹13,540.33L | ₹12,951.22L | ₹10,252.80L | ₹0.00L |
| Ordinary Shares Number | ₹159.21L | ₹158.04L | ₹156.90L | ₹155.72L | ₹0.00L |
| Current Debt | ₹11,899.98L | ₹10,324.96L | ₹10,047.62L | ₹7,662.73L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹3,141.34L | ₹3,772.36L | ₹3,174.81L | ₹2,926.72L | ₹0.00L |
| Current Liabilities | ₹21,950.03L | ₹20,305.72L | ₹20,933.44L | ₹16,564.47L | ₹0.00L |
| Net PPE | ₹7,536.65L | ₹6,695.97L | ₹6,419.92L | ₹6,111.79L | ₹0.00L |
| Retained Earnings | ₹2,731.04L | ₹2,205.21L | ₹1,468.86L | ₹1,358.13L | ₹0.00L |
| Construction In Progress | ₹437.56L | ₹264.93L | ₹201.99L | ₹554.49L | ₹0.00L |
| Common Stock Equity | ₹7,741.59L | ₹7,200.44L | ₹6,378.91L | ₹5,862.68L | ₹0.00L |
| Other Non Current Assets | ₹17.08L | ₹17.76L | ₹24.22L | -₹0.01L | ₹0.00L |
| Other Intangible Assets | ₹1,199.75L | ₹1,138.13L | ₹1,045.70L | ₹799.12L | ₹0.00L |
| Other Properties | ₹7,099.05L | ₹6,160.51L | ₹6,217.92L | ₹5,557.30L | ₹0.00L |
| Inventory | ₹10,302.22L | ₹8,781.15L | ₹9,800.50L | ₹7,439.56L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Changes In Cash | -₹244.43L | ₹270.86L | ₹37.43L | ₹8.92L |
| Financing Cash Flow | -₹784.24L | -₹120.63L | ₹2,409.38L | -₹1,722.15L |
| Investing Cash Flow | -₹1,491.69L | -₹1,889.09L | -₹2,218.24L | -₹948.48L |
| Free Cash Flow | ₹152.82L | ₹1,182.58L | -₹1,618.25L | ₹1,832.62L |
| End Cash Position | ₹175.16L | ₹419.58L | ₹148.71L | ₹111.26L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.01L | ₹0.01L | -₹0.01L |
| Capital Expenditure | -₹1,878.68L | -₹1,098.00L | -₹1,464.54L | -₹846.93L |
| Beginning Cash Position | ₹419.58L | ₹148.71L | ₹111.27L | ₹102.35L |
| Operating Cash Flow | ₹2,031.50L | ₹2,280.58L | -₹153.71L | ₹2,679.55L |
| Issuance Of Capital Stock | ₹14.12L | ₹50.12L | ₹391.71L | ₹91.28L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | ₹100.80L | ₹104.92L | ₹76.36L | ₹56.44L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹721.54L | ₹739.22L | ₹257.17L | ₹561.15L | ₹0.00L |
| EBITDA | ₹2,944.65L | ₹3,360.08L | ₹2,437.28L | ₹2,709.76L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Expenses | ₹27,417.13L | ₹30,457.01L | ₹28,416.23L | ₹26,463.92L | ₹0.00L |
| Operating Revenue | ₹30,308.33L | ₹32,634.50L | ₹30,170.73L | ₹27,969.89L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹8.27L | ₹13.29L | ₹224.28L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹1.46L | ₹3.16L | ₹64.68L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹8.27L | ₹13.29L | ₹224.28L | ₹0.00L |
| Interest Expense Non Operating | ₹1,685.44L | ₹1,448.23L | ₹1,049.60L | ₹887.52L | ₹0.00L |
| General And Administrative Expense | ₹461.96L | ₹462.74L | ₹342.36L | ₹270.54L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹721.53L | ₹739.22L | ₹257.17L | ₹561.15L | ₹0.00L |
| Reconciled Depreciation | ₹977.09L | ₹1,007.11L | ₹912.83L | ₹904.01L | ₹0.00L |
| Net Income Continuous Operations | ₹723.67L | ₹744.58L | ₹261.93L | ₹570.48L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹15,789.34L | ₹19,518.60L | ₹17,624.39L | ₹16,781.83L | ₹0.00L |
| Operating Income | ₹1,978.90L | ₹2,177.49L | ₹1,754.50L | ₹1,505.97L | ₹0.00L |
| Net Income | ₹721.54L | ₹739.22L | ₹257.17L | ₹561.15L | ₹0.00L |
| Diluted Average Shares | ₹158.23L | ₹157.38L | ₹156.90L | ₹148.22L | ₹0.00L |
| Selling And Marketing Expense | ₹1,939.30L | ₹1,744.65L | ₹1,477.41L | ₹1,481.69L | ₹0.00L |
| Normalized Income | ₹721.54L | ₹732.41L | ₹247.04L | ₹401.55L | ₹0.00L |
| Total Other Finance Cost | ₹251.62L | ₹176.08L | ₹181.78L | ₹203.36L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹1,685.44L | -₹1,410.58L | -₹1,208.25L | -₹1,053.87L | ₹0.00L |
| Gross Profit | ₹13,299.45L | ₹13,115.90L | ₹12,546.34L | ₹11,188.06L | ₹0.00L |
| EBIT | ₹1,967.56L | ₹2,195.19L | ₹1,524.45L | ₹1,805.75L | ₹0.00L |
| Cost Of Revenue | ₹16,127.86L | ₹19,518.60L | ₹17,624.39L | ₹16,781.83L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹721.53L | ₹739.22L | ₹257.17L | ₹561.15L | ₹0.00L |
| Net Interest Income | -₹1,685.44L | -₹1,410.58L | -₹1,208.25L | -₹1,053.87L | ₹0.00L |
| Normalized EBITDA | ₹3,176.28L | ₹3,360.08L | ₹2,423.99L | ₹2,485.48L | ₹0.00L |
| Operating Expense | ₹11,289.27L | ₹10,938.41L | ₹10,791.84L | ₹9,682.09L | ₹0.00L |
| Net Income Common Stockholders | ₹721.54L | ₹739.22L | ₹257.17L | ₹561.15L | ₹0.00L |
| Pretax Income | ₹513.75L | ₹904.73L | ₹474.85L | ₹918.23L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹30,308.33L | ₹33,921.96L | ₹30,170.73L | ₹27,969.89L | ₹0.00L |
| Selling General And Administration | ₹2,401.26L | ₹2,207.39L | ₹1,819.77L | ₹1,752.23L | ₹0.00L |
| Other Operating Expenses | ₹5,322.95L | ₹2,856.42L | ₹2,658.95L | ₹2,305.50L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹1,685.44L | ₹1,448.23L | ₹1,049.60L | ₹887.52L | ₹0.00L |
| Basic Average Shares | ₹158.53L | ₹157.38L | ₹156.90L | ₹148.22L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹723.67L | ₹744.57L | ₹261.93L | ₹570.48L | ₹0.00L |
| Tax Provision | -₹209.92L | ₹160.16L | ₹212.92L | ₹347.75L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/08/2004 | Shailesh Siroya | 00048109 | Managing Director | View other directorships |
| 28/09/2019 | Virupakshaya Himesh | 08554422 | Whole-time director | View other directorships |
| 23/05/2020 | Harihara Subramanian Venkatesh | 01776040 | Director | View other directorships |
| 23/05/2020 | Nicola Neeladri | 01997936 | Director | View other directorships |
| 28/12/2020 | Jatish Sheth | 00581963 | Director | View other directorships |
| 30/05/2022 | Chittanand Damodar Kotian | 09613054 | Whole-time director | View other directorships |
| 06/02/2023 | Daddanala Venkat Bharath Bhushan | *****2220C | CFO | |
| 17/07/2023 | Abdul Basith | *****9593B | Company Secretary |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 17/12/2024 | Form Addendum to AOC-4 CSR-17122024_signed | - |
| 26/11/2024 | Form MGT-7-20112024 | - |
| 17/10/2024 | Form AOC-4(XBRL)-16102024 | - |
| 25/03/2024 | Form Addendum to AOC-4 CSR-25032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| A D S Diagnostic Limited | L85110DL1984PLC018486 | 114 Sant Nagar East Of Kailash, New Delhi, Delhi, India, 110065 |
| Amar Diagnostic Centre And Hospital Limited | L85110AP1991PLC012297 | 29-6-29;r.r.road;suryaraopet; Vijayawada; Krishna Dist.; A.p; Andhra Pradesh; 000000; India |
| Artemis Medicare Services Limited | L85110DL2004PLC126414 | Plot No. 14 Sector 20, South West Delhi, Dwarka, Delhi, India, 110075 |
| Emed.com Technologies Limited. | L85110AP1989PLC009748 | 8-2-87-89, 4th Floor, Left Hand Side,srinivasa Plaza,srinagar Colony,main Road,hyderaba, D, Hyderabad, Telangana, India, 500082 |
| Religare Technova Global Solutions Limited | L85110DL1994PLC166888 | 25; Nehru Place; New Delhi; South Delhi; Delhi; 110019; India |
Address
21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099
Frequently Asked Questions
What is the incorporation date of Bal Pharma Limited?
The incorporation date of Bal Pharma Limited is 19/05/1987.
What is the authorized share capital and paid-up capital of Bal Pharma Limited?
The authorized share capital of Bal Pharma Limited is ₹20,00,00,000.00. The paid-up capital is ₹15,92,08,720.00.
Who are the current board members & directors of Bal Pharma Limited?
The current board member of Bal Pharma Limited are:
- Jatish Sheth
- Jatish Sheth
- Shailesh Siroya
- Virupakshaya Himesh
- Chittanand Damodar Kotian
- Harihara Subramanian Venkatesh
- Nicola Neeladri
What is the registered address of Bal Pharma Limited?
The registered address of Bal Pharma Limited is 21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099.
What is the Corporate Identification Number of Bal Pharma Limited?
The Corporate Identification Number of Bal Pharma Limited is L85110KA1987PLC008368.